A Promising Treatment for Eosinophilic Gastritis and Duodenitis

A monoclonal antibody reduced tissue eosinophils and improved symptoms in a phase II trial.

Source link

Related posts

Gastric Intestinal Metaplasia (GIM) Clinical Decision Support Tool


The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective


FDA Approves Mavyret for Children, Adolescents With Hep C


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy